14.25
-0.34 (-2.33%)
| Previous Close | 14.59 |
| Volume | 96,842 |
| Price / Earnings (Forward) | 161.29 |
| Price / Sales | 4.57 |
| Price / Book | 42.03 |
| 52 Weeks Range |
| Profit Margin | -29.42% |
| Operating Margin (TTM) | -22.85% |
| Diluted EPS (TTM) | -0.820 |
| Quarterly Revenue Growth (YOY) | 24.30% |
| Total Debt/Equity (MRQ) | 301.42% |
| Current Ratio (MRQ) | 6.63 |
| Operating Cash Flow (TTM) | -17.90 M |
| Levered Free Cash Flow (TTM) | -9.89 M |
| Return on Assets (TTM) | -11.52% |
| Return on Equity (TTM) | -128.49% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Neuropace, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | -1.0 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | 0.5 |
| Average | 0.38 |
|
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 2.75% |
| % Held by Institutions | 86.29% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| WILLIAMS PATRICK F. | - | 14.28 | -1,162 | -16,593 |
| Aggregate Net Quantity | -1,162 | |||
| Aggregate Net Value ($) | -16,593 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 14.28 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| WILLIAMS PATRICK F. | Officer | 20 Sep 2026 | Disposed (-) | 1,162 | 14.28 | 16,593 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |